Intercalation and photophysical characterization of 1-pyrenemethylamine in zirconium phosphate layered materials

Pyrene-based metal organic frameworks: from synthesis to applications

Pyrene is one of the most widely investigated aromatic hydrocarbons given to its unique optical and electronic properties. Hence, pyrene-based ligands have been attractive for the synthesis of metal-organic frameworks (MOFs) in the last few years. In this review, we will focus on the most important characteristics of pyrene, in addition to the development and synthesis of pyrene-based molecules as bridging ligands to be used in MOF structures. We will summarize the synthesis attempts, as well as the post-synthetic modifications of pyrene-based MOFs by the incorporation of metals or ligands in the structure. The discussion of promising results of such MOFs in several applications; including luminescence, photocatalysis, adsorption and separation, heterogeneous catalysis, electrochemical applications and bio-medical applications will be highlighted. Finally, some insights and future prospects will be given based on the studies discussed in the review. This review will pave the way for the researchers in the field for the design and development of novel pyrene-based structures and their utilization for different applications.

Zirconium phosphate nanoplatelets: a biocompatible nanomaterial for drug delivery to cancer

The objective of this study was to evaluate the biocompatibility of zirconium phosphate (ZrP) nanoplatelets (NPs), and their use in drug delivery. ZrP and doxorubicin-intercalated ZrP (DOX:ZrP) NPs were characterized by using X-Ray Powder Diffraction (XRPD), Thermogravimetric Analysis (TGA), Transmission Electron Micrography (TEM), Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM). Biocompatibility of ZrP NPs was evaluated in human embryonic kidney (HEK-293), breast cancer (MCF-7), metastatic breast cancer (MDA-MB-231), ovarian cancer (OVCAR-3), resistant cancer (NCI-RES/ADR) cells and mouse macrophage (RAW 264.7) cell lines. Hemocompatibility of ZrP NPs was evaluated with human red blood cells. Simulated body fluid (SBF) of pH 7.4 was used to determine the in vitro release of doxorubicin from DOX:ZrP NPs. Cellular uptake and in vitro cytotoxicity studies of DOX:ZrP NPs were determined in MDA-MB-231. The ZrP nanomaterial can be prepared in the 100-200 nm size range with a platelet-like shape. The ZrP NPs themselves are biocompatible, hemocompatible and showed no toxicity to the macrophage cells. ZrP NPs can intercalate high loads (35% w/w) of doxorubicin between their layers. The release of DOX was sustained for about 2 weeks. DOX:ZrP NPs showed higher cellular uptake and increased cytotoxicity than free DOX in MDA-MB-231 cells. ZrP NPs are highly biocompatible, can intercalate large amounts of drugs and sustain the release of drugs. ZrP NPs improved the cellular uptake and cytotoxicity of DOX to MDA-MB-231 cells. ZrP NPs are promising nanocarriers for drug delivery in cancer therapy.

Direct intercalation of bis-2,2',2″,6-terpyridylcobalt(III) into zirconium phosphate layers for biosensing applications

The direct intercalation reaction of [Co(tpy)(2)](2+) with the highly hydrated θ phase of layered zirconium phosphate (θ-ZrP) resulted in the formation of the oxidized [Co(tpy)(2)](3+) ion within the ZrP material. The X-ray powder diffraction patterns showed that the interlayer distance increases from 10.3 Å in θ-ZrP to 14.9 Å in the dry [Co(tpy)(2)](3+)-intercalated ZrP {[Co(tpy)(2)](3+):ZrP} phase. The complex remains electroactive within the layers of ZrP. The formal potential of a carbon paste electrode (CPE) modified with [Co(tpy)(2)](3+):ZrP (E°' = 40.8 mV versus Ag/AgCl, 3.5 M NaCl) is non-pH-dependent. However, the sensitivity of the [Co(tpy)(2)](3+):ZrP-modified CPE for the detection of reduced nicotinamide adenine dinucleotide (NADH) electrooxidation was lower than that of a previously reported CPE modified with [Ru(phend)(2)bpy](2+)-intercalated ZrP. (1) To improve the characteristics of NADH electrooxidation of the [Co(tpy)(2)](3+):ZrP-modified CPE, we included the enzyme diaphorase in solution, which increased the electrocatalytic current for NADH oxidation. A bienzymatic lactate biosensor was constructed and used for lactate sensing.

Zirconium phosphate nano-platelets: a novel platform for drug delivery in cancer therapy

Doxorubicin was intercalated into novel zirconium phosphate nano-platelets (ZrP). The obtained doxorubicin intercalated ZrP nano-platelets had an impressive 34.9% (w/w) drug loading. We used this material to deliver doxorubicin to breast cancer cells (MCF-7). Cellular studies with MCF-7 cells showed higher uptake and cytotoxicity of doxorubicin loaded ZrP compared to free doxorubicin.

Antimicrobial effects of quaternary phosphonium salt intercalated clay minerals on Escherichia coli and Staphylococci aureus

The aim of this research was to determine the antimicrobial properties and influence factors of four clay minerals intercalated by quaternary phosphonium salt (tetradecyl tributyl phosphonium bromide, TDTB) on antimicrobial effects. Escherichia coli (E. coli) and Staphylococci aureus (S. aureus) were chosen for Minimal Inhibitory Concentration (MIC) tests to evaluate the antimicrobial activities of organ-clay minerals. The properties of organ-clay minerals were analyzed by FTIR, XRD, TEM, Z-Average and Zeta potential, and the releasing amount of TDTB into the broth was measured by ICP. The results showed that montmorillonites-TDTB inhibited the growth of E. coli and S. aureus, and the MICs were 200 ± 20 and 80 ± 15 mg/L, respectively. The amount of TDTB released into the broth was 3.42 ± 0.71%. According to the properties of organ-clay mineral, it was indicated that the antimicrobial activities of organ-clay mineral were the synergic effect of the releasing amount of TDTB, Zeta potential, particle size and distribution. The organ-clay mineral with the larger releasing amount of TDTB, the higher Zeta potential, the same particle size with bacterial size and the narrower size distribution exhibited better antimicrobial activity. The present study demonstrated the properties of organ-clay minerals effected their antimicrobial activities, provided theoretically guidance to promote the antimicrobial activity of clay minerals.

Nanoencapsulation of insulin into zirconium phosphate for oral delivery applications

The encapsulation of insulin into different kinds of materials for noninvasive delivery is an important field of study because of the many drawbacks of painful needle and syringe delivery such as physiological stress, infection, and local hypertrophy, among others (Khafagy, E.-S.; et al. Adv. Drug Delivery Rev. 2007, 59 (15), 1521-1546). A stable, robust, nontoxic, and viable noninvasive carrier for insulin delivery is needed. We present a new approach for protein nanoencapsulation using layered zirconium phosphate (ZrP) nanoparticles produced without any preintercalator present. The use of ZrP without preintercalators produces a highly pure material, without any kinds of contaminants, such as the preintercalator, which can be noxious. Cytotoxicity cell viability in vitro experiments for the ZrP nanoparticles show that ZrP is not toxic, or harmful, in a biological environment, as previously reported for rats (Zhu, Z. Y.; et al. Mater. Sci. Forum 2009, 620-622, 307-310). Contrary to previous preintercalator-based methods, we show that insulin can be nanoencapsulated in ZrP if a highly hydrate phase of ZrP with an interlayer distance of 10.3 Å (10.3 Å-ZrP or θ-ZrP) is used as a precursor. The intercalation of insulin into ZrP produced a new insulin-intercalated ZrP phase with about a 27 A interlayer distance, as determined by X-ray powder diffraction, demonstrating a successful nanoencapsulation of the hormone. The in vitro release profile of the hormone after the intercalation was determined and circular dichroism was used to study the hormone stability upon intercalation and release. The insulin remains stable in the layered material, at room temperature, for a considerable amount of time, improving the shell life of the peptidic hormone. This type of material represents a strong candidate to developing a noninvasive insulin carrier for the treatment of diabetes mellitus.

Room-Temperature Emission from Platinum(II) Complexes Intercalated into Zirconium Phosphate-Layered Materials

The direct ion exchange of chloro(2,6-bis(N-methylbenzimidazol-2-yl)pyridine)platinum(II) ([Pt(Me(2)bzimpy)Cl]+) and chloro(2,2':6',2' '-terpyridine)platinum(II) ([Pt(tpy)Cl]+) complexes within a zirconium phosphate (ZrP) framework has been accomplished. The physical and spectroscopic properties of [Pt(Me(2)bzimpy)Cl]+ and [Pt(tpy)Cl]+ intercalated in ZrP were investigated by X-ray powder diffraction and X-ray photoelectron, infrared, absorption, and luminescence spectroscopies. In contrast to unintercalated complexes in fluid solution, which do not emit at room temperature, both intercalated materials in the solid state and in colloidal suspensions exhibit intense emissions at room temperature. A [Pt(Me(2)bzimpy)Cl]+-exchanged ZrP colloidal methanol suspension gives rise to an emission at 612 nm that originates from a lowest (3)MMLCT[dsigma*(Pt) --> pi*(tpy)] state (MMLCT = metal-metal-to-ligand charge transfer) characteristic of strong Pt...Pt interactions. A [Pt(tpy)Cl]+-exchanged ZrP colloidal aqueous suspension exhibits a strong emission band at 600 nm. The accumulated data demonstrate that at high concentrations, [Pt(Me(2)bzimpy)Cl]+ and [Pt(tpy)Cl]+ ions can serve as luminescent pillars inside the ZrP framework.

Layered inorganic materials as redox agents: ferrocenium-intercalated zirconium phosphate

The direct intercalation reaction of ferrocene (bis(eta5-cyclopentadienyl)iron(II), Fc) with a highly hydrated layered zirconium phosphate (ZrP) resulted in the formation of the ferrocenium ion (Fc+) within the ZrP material. The Fc+-intercalated ZrP material has an interlayer distance of 10.7 A. The intercalated material was used as an electron acceptor for the oxidation of both ferro-cytochrome c and the excited state of tris(2,2'-bipyridine)ruthenium(II) ([Ru(bpy)3]2+). Upon contact of the material with a 1.5 x 10(-5) M solution of ferro-cytochrome c, the UV-vis absorption spectrum shows the successful formation of ferri-cytochrome c. Luminescence spectroscopy shows that the Fc+-intercalated ZrP material quenches the luminescence of [Ru(bpy)3]2+. The excited-state quenching mechanism of [Ru(bpy)3]2+* by Fc+-intercalated ZrP follows a dynamic plus sphere of action model. The second-order dynamic quenching rate constant kq is 2.2 x 10(8) M(-1) s(-1).

NADH Electrooxidation Using Bis(1,10-phenanthroline-5,6-dione) (2,2'-bipyridine)ruthenium(II)-Exchanged Zirconium Phosphate Modified Carbon Paste Electrodes

We present a carbon paste electrode (CPE) modified using the electron mediator bis(1,10-phenanthroline-5,6-dione) (2,2'-bipyridine)ruthenium(II) ([Ru(phend)(2)bpy](2+)) exchanged into the inorganic layered material zirconium phosphate (ZrP). X-Ray powder diffraction showed that the interlayer distance of ZrP increases upon [Ru(phend)(2)bpy](2+) intercalation from 10.3 Å to 14.2 Å. The UV-vis and IR spectroscopies results showed the characteristic peaks expected for [Ru(phend)(2)bpy](2+). The UV-vis spectrophotometric results indicate that the [Ru(phend)(2)bpy](2+) concentration inside the ZrP layers increased as a function of the loading level. The exchanged [Ru(phend)(2)bpy](2+) exhibited luminescence even at low concentration. Modified CPEs were constructed and analyzed using cyclic voltammetry. The intercalated mediator remained electroactive within the layers (E°' = -38.5 mV vs. Ag/AgCl, 3.5 M NaCl) and electrocatalysis of NADH oxidation was observed. The kinetics of the modified CPE shows a Michaelis -Menten behavior. This CPE was used for the oxidation of NADH in the presence of Bakers' yeast alcohol dehydrogenase. A calibration plot for ethanol is presented.